- Home
- CVKD vs ANEB Comparison
CVKD vs ANEB Comparison
Compare CVKD & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- ANEB
- Stock Information
- Founded
- CVKD 2022
- ANEB 2020
- Country
- CVKD United States
- ANEB United States
- Employees
- CVKD N/A
- ANEB N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- CVKD Health Care
- ANEB Health Care
- Exchange
- CVKD Nasdaq
- ANEB Nasdaq
- Market Cap
- CVKD 31.5M
- ANEB 36.7M
- IPO Year
- CVKD 2023
- ANEB 2021
- Fundamental
- Price
- CVKD $16.75
- ANEB $1.01
- Analyst Decision
- CVKD Strong Buy
- ANEB Buy
- Analyst Count
- CVKD 1
- ANEB 1
- Target Price
- CVKD $32.00
- ANEB $8.00
- AVG Volume (30 Days)
- CVKD 22.9K
- ANEB 34.3K
- Earning Date
- CVKD 05-08-2025
- ANEB 05-14-2025
- Dividend Yield
- CVKD N/A
- ANEB N/A
- EPS Growth
- CVKD N/A
- ANEB N/A
- EPS
- CVKD N/A
- ANEB N/A
- Revenue
- CVKD N/A
- ANEB N/A
- Revenue This Year
- CVKD N/A
- ANEB N/A
- Revenue Next Year
- CVKD N/A
- ANEB N/A
- P/E Ratio
- CVKD N/A
- ANEB N/A
- Revenue Growth
- CVKD N/A
- ANEB N/A
- 52 Week Low
- CVKD $5.70
- ANEB $0.80
- 52 Week High
- CVKD $22.90
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- CVKD 49.23
- ANEB 39.13
- Support Level
- CVKD $14.10
- ANEB $0.94
- Resistance Level
- CVKD $17.39
- ANEB $1.12
- Average True Range (ATR)
- CVKD 1.57
- ANEB 0.13
- MACD
- CVKD 0.04
- ANEB -0.01
- Stochastic Oscillator
- CVKD 54.19
- ANEB 22.00
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.